Sarasota, FL -- (SBWire) -- 12/06/2016 --Global Radiopharmaceutical Market by Type (Diagnostic Radiopharmaceuticals and Therapeutic radiopharmaceuticals), for Cardiology, Neurology, Oncology and Other Applications- Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021
The report covers forecast and analysis for the radiopharmaceutical market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million) and volume. The study includes drivers and restraints for the radiopharmaceutical along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the radiopharmaceutical market on a global level.
Global Radiopharmaceutical Market 2014 - 2020
In order to give the users of this report a comprehensive view on the radiopharmaceutical market, we have included a detailed segmentation of radiopharmaceutical. To understand the competitive landscape in the market, an analysis of Porter's Five Forces model for the radiopharmaceutical market has also been included. The study encompasses a market attractiveness analysis, wherein application segments are benchmarked based on their market size, growth rate, and general attractiveness.
Click Here to Get Sample Copy of Report
The study provides a decisive view on the radiopharmaceutical market by segmenting the market based on type and application. Diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals are the type segment of Radiopharmaceuticals market. Cardiology, neurology, oncology and other are the key application segment of radiopharmaceutical market. All the application segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021.
Some of the major players in the radiopharmaceuticals market include Cardinal Health, Inc., GE Healthcare, Bracco Imaging S.p.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications S.A., Bayer Healthcare, Lantheus Medical Imaging, Inc., IBA Molecular Imaging, Mallinckrodt plc, Jubilant Pharma, and Siemens Healthcare.
Browse more detail information about Report at http://atozresearch.com/global-radiopharmaceutical-market-size-share-growth-segment/
The report segments the global radiopharmaceuticals market as:
Radiopharmaceuticals Market: Type Segment Analysis
Diagnostic Radiopharmaceuticals
SPECT
PET
Therapeutic radiopharmaceuticals
Beta emitters
Alpha emitters
Brachytherapy isotopes
Radiopharmaceuticals Market: Application Segment Analysis
Cardiology
Neurology
Oncology
Other
Request For Toc at http://atozresearch.com/global-radiopharmaceutical-market-size-share-growth-segment/#tabs-2884-0-1
About A to Z Research
A to Z Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations. A to Z Research is the comprehensive collection of market intelligence products and services available on air. We have market research reports from number of leading publishers and update our collection daily to provide our clients with the instant online access to our database. With access to this database, our clients will be able to benefit from expert insights on global industries, products, and market trends.
Global Radiopharmaceutical Market - Cardinal Health, Inc., GE Healthcare, Bracco Imaging S.p.A, Nordion, Bayer Healthcare
Global Radiopharmaceutical Market – Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021